ACN - Company News

Press Releases


Monday, June 30, 2014

聯康生物科技集團公佈二零一三/一四年度全年營業額跑贏行業增長水平
聯康生物科技集團有限公司(「聯康生物」或「集團」)( 股份代號：690)於二零一三/一四財政年度表現卓越。除了營業額增長跑贏行業平均水平外，集團旗下兩款新處方藥品Uni-E4及Uni-PTH完成所有規定臨床測試。 more info >>

Uni-Bio Science Group 2013/14 Annual Turnover Beats Industry Growth
Uni-Bio Science Group Limited ("Uni-Bio" or the "Group;" HKEx code: 690) has achieved an outstanding performance during the financial year 2013/14. The Group's topline growth beat the industry average while its two new prescription drugs, Uni-E4 and Uni-PTH, both reached major clinical milestone of completing all required clinical trials. more info >>

联康生物科技集团旗下骨质疏松药物Uni-PTH达致第三期主要疗效指标
联康生物科技集团有限公司(「联康生物」或「集团」)( 股份代号：690)今天宣布，每天一次、用以治疗骨质疏松的新处方药Uni-PTH的第三期临床研究结果成功。 more info >>

聯康生物科技集團旗下骨質疏鬆藥物Uni-PTH達致第三期主要療效指標
聯康生物科技集團有限公司(「聯康生物」或「集團」)( 股份代號：690)今天宣布，每天一次、用以治療骨質疏鬆的新處方藥Uni-PTH的第三期臨床研究結果成功。 more info >>

Uni-Bio Science Group's Osteoporosis Drug Uni-PTH Meets Phase III Primary Endpoint
Uni-Bio Science Group Limited ("Uni-Bio" or the "Group;" HKEx code: 690) today reports successful Phase III clinical trial results of Uni-PTH, a once-daily prescription new drug for osteoporosis. more info >>

Tuesday, April 1, 2014

联康生物科技集团委任行业专家加强高级管理层及董事会组成
联康生物科技集团有限公司(「联康生物」或「集团」)( 股份代号：690)加强董事会及高级管理团队组成，以巩固业务基础及推行新的业务发展策略。集团的经营及业务重组策略将进一步优化整体业务营运，为集团提供一个更稳固的平台以推动业务增长。 more info >>

聯康生物科技集團委任行業專家加強高級管理層及董事會組成
聯康生物科技集團有限公司(「聯康生物」或「集團」)( 股份代號：690)加強董事會及高級管理團隊組成，以鞏固業務基礎及推行新的業務發展策略。 more info >>

Uni-Bio Science Group Bolsters Top Management and Board with Industry Veterans
Uni-Bio Science Group Limited ("Uni-Bio" or the "Group") (SEHK code: 690) strengthened the composition of the Board of Directors ("Board") and senior management team to enhance business fundamentals and to initiate new business development strategies. more info >>


1 2 3 4 5 6

Latest Press Releases

Spritzer Scores Big with 'Meet the Red Legends' Event for Football Fans Apr 28, 2024 18:00 HKT/SGT

Announcing Mad About Marketing - A New Member of the Digital Sukoon Private Limited Family Apr 28, 2024 17:00 HKT/SGT

HKTDC unveils gifts, printing, packaging and licensing events Apr 27, 2024 21:00: JST

HKTDC unveils gifts, printing, packaging and licensing events Apr 27, 2024 20:00 HKT/SGT

Masverse Unveils Groundbreaking Blockchain Platform Apr 27, 2024 02:40 HKT/SGT

Spritzer Scores Big with 'Meet the Red Legends' Event for Football Fans Apr 27, 2024 00:00: JST

Announcing Mad About Marketing - A New Member of the Digital Sukoon Private Limited Family Apr 26, 2024 23:25: JST

FinTech Funding Continues to Surge as Second Edition of Dubai FinTech Summit Commences Apr 26, 2024 21:10 HKT/SGT

汇聚科技有限公司公布截至二零二三年十二月三十一日止末期业绩 Apr 26, 2024 18:53 HKT/SGT

匯聚科技有限公司公佈截至二零二三年十二月三十一日止末期業績 Apr 26, 2024 18:43 HKT/SGT

UK advertising reports GBP36.6bn spend in 2023 Apr 26, 2024 18:30: JST

TIME Interconnect Technology Limited Announces Final Results For The Nine Months Ended 31 December 2023 Apr 26, 2024 18:26 HKT/SGT

UK advertising reports GBP36.6bn spend in 2023 Apr 26, 2024 17:30 HKT/SGT

CanSinoBIO CSO Shares the Latest Results of the Company's Globally Innovative Pneumococcal Vaccine Apr 26, 2024 16:36: JST

CanSinoBIO CSO Shares the Latest Results of the Company's Globally Innovative Pneumococcal Vaccine Apr 26, 2024 15:36 HKT/SGT


More News >>


Home \| About us \| Services \| Partners \| Events \| Login \| Contact us \| Cookies Policy \| Privacy Policy \| Disclaimer \| Terms of Use \| RSS

US: +1 214 890 4418 \| China: +86 181 2376 3721 \| Hong Kong: +852 8192 4922 \| Singapore: +65 6549 7068 \| Tokyo: +81 3 6859 8575